LUPIN
Back to Income Statement
|
LUPIN Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹3,282 Cr | ₹1,914 Cr | ₹430 Cr | ₹-1,528 Cr | ₹1,217 Cr |
What is the latest Consolidated Net Profit of LUPIN ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹3,282 Cr |
| Mar2025 | ₹1,914 Cr |
| Mar2024 | ₹430 Cr |
| Mar2023 | ₹-1,528 Cr |
| Mar2022 | ₹1,217 Cr |
How is Consolidated Net Profit of LUPIN Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,282 Cr | 71.41 | |
| Mar2025 | ₹1,914 Cr | 345.15 | |
| Mar2024 | ₹430 Cr | Positive | |
| Mar2023 | ₹-1,528 Cr | Negative | |
| Mar2022 | ₹1,217 Cr | - | |
Compare Consolidated Net Profit of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹98,077.1 Cr | 2.3% | -3.4% | 2.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | 2.3% |
-3.4% |
2.4% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses